NCT00995007: A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas |
|
|
| Completed | 2 | 112 | US | ZD6474 (Vandetanib), Carboplatin | National Cancer Institute (NCI) | Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma | 06/15 | 12/15 | | |
